PharmaCorp Rx Inc
XTSX:PCRX
PharmaCorp Rx Inc
XTSX:PCRX
Price:
0.45
CAD
Market Closed
Market Cap:
CA$78.3m
Wall Street
Price Targets
PCRX Price Targets Summary
PharmaCorp Rx Inc
PharmaCorp Rx Inc
Wall Street analysts forecast PCRX stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
PCRX
is 0.59 CAD
with a low forecast of 0.51 CAD and a high forecast of 0.68 CAD.
Lowest
Price Target
0.51
CAD
12% Upside
Average
Price Target
0.59
CAD
30% Upside
Highest
Price Target
0.68
CAD
52% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PCRX's stock price target?
Price Target
0.59
CAD
0.59
CAD
According to Wall Street analysts, the average 1-year price target for
PCRX
is 0.59 CAD
with a low forecast of 0.51 CAD and a high forecast of 0.68 CAD.
What is PharmaCorp Rx Inc's Revenue forecast?
Projected CAGR
138%
138%
The
compound annual growth rate
of PharmaCorp Rx Inc's revenue for the next 3 years is
138%.
